Shares of Quintiles IMS Holdings Inc (NYSE:Q) have been assigned an average rating of “Hold” from the twenty-one brokerages that are covering the stock. Two analysts have rated the stock with a sell recommendation, eleven have issued a hold recommendation and eight have given a buy recommendation to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $82.93.
Q has been the subject of a number of research analyst reports. Zacks Investment Research downgraded shares of Quintiles IMS Holdings from a “hold” rating to a “sell” rating in a report on Wednesday, February 15th. Deutsche Bank AG downgraded shares of Quintiles IMS Holdings from a “buy” rating to a “hold” rating and cut their price target for the company from $81.00 to $80.00 in a report on Friday, February 3rd. Robert W. Baird downgraded shares of Quintiles IMS Holdings from a “neutral” rating to an “underperform” rating and cut their price target for the company from $80.00 to $74.00 in a report on Wednesday, February 15th. Credit Suisse Group AG began coverage on shares of Quintiles IMS Holdings in a report on Friday, March 31st. They set an “outperform” rating and a $89.00 target price for the company. Finally, Jefferies Group LLC restated a “hold” rating and set a $78.00 target price on shares of Quintiles IMS Holdings in a report on Monday, April 3rd.
ILLEGAL ACTIVITY NOTICE: “Quintiles IMS Holdings Inc (Q) Receives Average Rating of “Hold” from Brokerages” was originally posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this piece of content on another website, it was stolen and republished in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.chaffeybreeze.com/2017/04/21/quintiles-ims-holdings-inc-q-receives-82-93-average-target-price-from-brokerages-updated.html.
Shares of Quintiles IMS Holdings (NYSE:Q) traded down 0.45% during midday trading on Tuesday, reaching $82.51. 438,544 shares of the company’s stock were exchanged. The stock’s 50-day moving average is $79.31 and its 200 day moving average is $77.57. Quintiles IMS Holdings has a one year low of $61.21 and a one year high of $83.04. The firm has a market cap of $19.45 billion, a PE ratio of 108.57 and a beta of 0.68.
Quintiles IMS Holdings (NYSE:Q) last announced its quarterly earnings results on Tuesday, February 14th. The medical research company reported $1.09 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.05 by $0.04. The business earned $1.95 billion during the quarter, compared to the consensus estimate of $1.97 billion. Quintiles IMS Holdings had a net margin of 6.55% and a negative return on equity of 212.51%. The business’s revenue was up 73.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.90 EPS. Analysts anticipate that Quintiles IMS Holdings will post $4.48 EPS for the current year.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Toronto Dominion Bank raised its stake in Quintiles IMS Holdings by 158.5% in the third quarter. Toronto Dominion Bank now owns 1,272 shares of the medical research company’s stock worth $103,000 after buying an additional 780 shares in the last quarter. Bessemer Group Inc. purchased a new stake in Quintiles IMS Holdings during the fourth quarter worth about $136,000. Bronfman E.L. Rothschild L.P. raised its stake in Quintiles IMS Holdings by 36,400.0% in the third quarter. Bronfman E.L. Rothschild L.P. now owns 1,825 shares of the medical research company’s stock worth $148,000 after buying an additional 1,820 shares in the last quarter. Pitcairn Co. purchased a new stake in Quintiles IMS Holdings during the fourth quarter worth about $229,000. Finally, S&CO Inc. purchased a new stake in Quintiles IMS Holdings during the third quarter worth about $243,000. Hedge funds and other institutional investors own 45.89% of the company’s stock.
Quintiles IMS Holdings Company Profile
Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Quintiles IMS Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles IMS Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.